Loading organizations...
Key people at Hongdao Capital.
Hongdao Capital operates as a Beijing-based private equity and venture capital firm, specializing in investment management. The firm invests in companies developing breakthrough technologies, primarily in artificial intelligence, life sciences, and consumption upgrades. Its core approach involves providing strategic capital and portfolio management services to fuel the growth of promising ventures across these high-potential sectors.
Yilong Zhang founded Hongdao Capital, establishing the firm in February 2010. Zhang recognized an emerging landscape ripe for disruption and growth within China's rapidly evolving technological and consumer markets. This insight led to the creation of a dedicated investment platform aimed at capturing value from innovative enterprises positioned for significant future impact.
The firm's clients are early-stage and growth-oriented companies innovating in its target sectors. Hongdao Capital envisions itself as a pivotal partner in fostering next-generation technologies and market trends. It aims to accelerate the development of ventures that will reshape industries and contribute substantially to economic and technological progress.
Key people at Hongdao Capital.
Hongdao Capital has 2 tracked investments across 2 companies. The latest tracked deal is $40.0M Series C in XWPharma 凯瑞康宁 in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 20, 2020 | XWPharma 凯瑞康宁 | $40.0M Series C | — | Huachuang Yida, Johnson & Johnson Innovation, KTB Network, Sany Innovation Investment, WuXi AppTec, Zhongjinghe Group |
| Mar 2, 2018 | Wecash | $160.0M Series D | Orix Asia Capital, SEA | Forebright Capital, Lingfeng Capital, Sagamore Ventures, SIG |